Search research articles
Contact Us
Filters
Showing results (201-210 of 246) with videos related to
Page
of 25
Sort By:
Hypertension (Dallas, Tex. : 1979)
|
January 11, 2000
Retinal neovascularization is prevented by blockade of the renin-angiotensin system
C J Moravski, D J Kelly, M E Cooper, et al.
Circulation Research
|
January 11, 2000
Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibition
K Jandeleit-Dahm, K M Hannan, C A Farrelly, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 23, 2004
Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria
G Jerums, T J Allen, D J Campbell, et al.
Biotechniques
|
November 27, 2002
A pH-sensitive fluor, CypHer 5, used to monitor agonist-induced G protein-coupled receptor internalization in live cells
E J Adie, S Kalinka, L Smith, et al.
Diabetologia
|
August 18, 2001
Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade
S A Mifsud, T J Allen, J F Bertram, et al.
Current Eye Research
|
March 15, 2005
Identification of angiotensin converting enzyme 2 in the rodent retina
C Tikellis, C I Johnston, J M Forbes, et al.
Atherosclerosis
|
December 21, 2007
Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules
C Tikellis, K A Jandeleit-Dahm, K Sheehy, et al.
American Journal of Medical Genetics
|
May 9, 2001
Genetic segregation analysis of autonomic nervous system dysfunction in families of probands with idiopathic congenital central hypoventilation syndrome
M L Marazita, B S Maher, M E Cooper, et al.
Diabetologia
|
August 6, 2005
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study
G Boner, M E Cooper, K McCarroll, et al.
Diabetologia
|
June 21, 2007
Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties
A Hoang, A J Murphy, M T Coughlan, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 246) with videos related to
Sort By:
Page
of 25
Hypertension (Dallas, Tex. : 1979)
|
January 11, 2000
Retinal neovascularization is prevented by blockade of the renin-angiotensin system
C J Moravski, D J Kelly, M E Cooper, et al.
Circulation Research
|
January 11, 2000
Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibition
K Jandeleit-Dahm, K M Hannan, C A Farrelly, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 23, 2004
Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria
G Jerums, T J Allen, D J Campbell, et al.
Biotechniques
|
November 27, 2002
A pH-sensitive fluor, CypHer 5, used to monitor agonist-induced G protein-coupled receptor internalization in live cells
E J Adie, S Kalinka, L Smith, et al.
Diabetologia
|
August 18, 2001
Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade
S A Mifsud, T J Allen, J F Bertram, et al.
Current Eye Research
|
March 15, 2005
Identification of angiotensin converting enzyme 2 in the rodent retina
C Tikellis, C I Johnston, J M Forbes, et al.
Atherosclerosis
|
December 21, 2007
Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules
C Tikellis, K A Jandeleit-Dahm, K Sheehy, et al.
American Journal of Medical Genetics
|
May 9, 2001
Genetic segregation analysis of autonomic nervous system dysfunction in families of probands with idiopathic congenital central hypoventilation syndrome
M L Marazita, B S Maher, M E Cooper, et al.
Diabetologia
|
August 6, 2005
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study
G Boner, M E Cooper, K McCarroll, et al.
Diabetologia
|
June 21, 2007
Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties
A Hoang, A J Murphy, M T Coughlan, et al.
Page
of 25